Cancer Immunology, Immunotherapy
Q1 Journal
Open Access
Journal
Country
Germany
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Immunology
Q1
└
Immunology and Allergy
Q1
SJR 2025
1.805
Q1
SJR Score
H-Index
148
Citations / Doc (2yr)
5.56
Total Docs. (latest)
366
Total Citations (3yr)
4,563
Publication type
Journals
ISSN
14320851, 03407004
Coverage
1976-2026
Journal Rank
#1,736
Subject Categories
Cancer Research
Q1
Immunology
Q1
Immunology and Allergy
Q1
Medicine (miscellaneous)
Q1
Oncology
Q1
Aims & Scope
Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology.
As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers.
This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.
The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 366 |
| Total Docs. (3 years) | 828 |
| Total Refs. | 16,337 |
| Total Citations (3 years) | 4,563 |
| Citable Docs. (3 years) | 822 |
| Citations / Doc. (2 years) | 5.56 |
| Ref. / Doc. | 44.64 |
| % Female | 40.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.